已收盘 10-17 16:00:00 美东时间
-0.040
-1.29%
今日重点评级关注:Maxim Group:维持Gain Therapeutics"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Icecure Medical"买入"评级,目标价从2美元升至2.5美元
10-08 09:14
Cantor Fitzgerald analyst Sarah James reiterates Health Catalyst (NASDAQ:HCAT) with a Neutral and maintains $4 price target.
10-07 21:14
Healthmine (NASDAQ:HCAT) on Wednesday announced that its Board of Directors has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025. Erskine succeeds Bryce Willia...
09-24 20:42
Health Catalyst (NASDAQ:HCAT) on Wednesday said it has appointed Ben Albert as President and Chief Operating Officer, effective immediately. Albert, brings over 25 years of experience in leading healt...
09-11 04:34
SALT LAKE CITY, Sept. 9, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organiza...
09-09 20:30
BTIG analyst David Larsen reiterates Health Catalyst (NASDAQ:HCAT) from Neutral to Neutral.
09-05 18:46
Canaccord Genuity analyst Richard Close maintains Health Catalyst (NASDAQ:HCAT) with a Buy and lowers the price target from $9 to $5.
08-30 02:01
Recognizing Healthcare's Data-Driven Innovators at the 2025 Health Catalyst Analytics Summit SALT LAKE CITY, Aug. 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: H...
08-29 21:00
Top Wall Street analysts changed their outlook on these top names. For a comple...
08-27 23:34
Hospitals and Health Systems Can Now Benefit from a Validated Consumer Science Model and Proprietary Business Intelligence SALT LAKE CITY, Aug. 26, 2025 /PRNewswire/ -- Health Catalyst, Inc....
08-26 20:30